Robert Ticktin
Förmögenhet: 119 421 $ per 2026-08-31
Förmögenhet: 119 421 $ per 2026-08-31
Mr. Robert Ticktin is a COO, Secretary & General Counsel at PMV Pharmaceuticals, Inc. Mr. Ticktin was previously employed as an Associate General Counsel by Tesaro, Inc., a Senior Vice President & General Counsel by EPIRUS Biopharmaceuticals, Inc. /Old/, a Secretary, Senior Vice President & General Counsel by EPIRUS Biopharmaceuticals, Inc., and a Senior Vice President & General Counsel by Zalicus, Inc. He received his undergraduate degree from The Ohio State University and a graduate degree from Fordham University School of Law.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-07 | 98 695 ( 0,18 % ) | 119 421 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Verksamhetschef | 2024-12-01 |
| Företag | Position | Slut |
|---|---|---|
| TESARO INC | Företagsledare/Principal | 2020-06-01 |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies | Generell Rådgivare | 2016-08-01 |
| EPIRUS BIOPHARMACEUTICALS, INC. | Generell Rådgivare | - |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Generell Rådgivare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Health Technology |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies | Health Technology |
Fordham University School of Law
Fordham University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EPIRUS Biopharmaceuticals, Inc.
EPIRUS Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biosimilar monoclonal antibodies | Health Technology |
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån